Abstract
Objective
To evaluate the diagnostic performance of the tests included in primary Sjogren's syndrome (SS-I) diagnostic criteria (Schirmer I, break-up time, vital dye staining) and to compare them with other examinations related to the ocular surface status.
Methods
Clinical and cytological data were collected from 177 patients (62 SS-1, 56 non-SS autoimmune diseases, 59 Sicca syndrome). Tear tests included: a validated questionnaire on symptoms, Schirmer I, Jones test, Ferning test, BUT, corneal aesthesiometry, tear clearance test, lissamine green staining, impression conjunctival cytology. Data were statistically evaluated and sensitivity, specificity, likelihood ratio (LR+), receiver-operating characteristics (ROC) curves were calculated for each test.
Results
Data showed a poor diagnostic performance of Schirmer test I (sensitivity 0.42; specificity 0.76; LR+1.75) and BUT (sensitivity 0.92; specificity 0.17; LR+1.11) (area under the curve in ROC analysis <0.58). Validated subjective symptoms questionnaire (sensitivity 0.89; specificity 0.72; LR+3.18), Jones test (sensitivity 0.60; specificity 0.88; LR+5), corneal aesthesiometry (sensitivity 0.80; specificity 0.67; LR+2.42), and tear clearance test (sensitivity 0.63; specificity 0.84; LR+3.93), all exhibited a high diagnostic performance (area under the curve in the ROC analysis always >0.70). Lissamine green staining exhibited the best performance (sensitivity 0.63; specificity 0.89; LR+5.72) but the result could be distorted by an incorporation bias.
Conclusions
Our data suggest to implement the items for ocular signs and symptoms contained in many SS-I diagnostic criteria with the use of a validated questionnaire, performance of Jones test, corneal aesthesiometry measurement, and tear clearance rate evaluation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
O'Day DM, Horn JD . The eye and rheumatic disease. In: Kelley WN (ed). Textbook of Rheumatology, 6th ed. Saunders: Philadelphia, 2001 Chapter 29.
Thomas E, Hay EM, Hajeer A, Silman AJ . Sjogren's syndrome: a community-based study of prevalence and impact. Br J Rheum 1998; 37: 1069–1076.
Martin-Martin LS, Latini A, Pagano A, Ragno A, Stasi R . A new mathematical model based on clinical and laboratory variables for the diagnosis of Sjogren's syndrome. Clin Rheumatol 2003; 22: 123–126.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM . Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–558.
Tseng SC, Tsubota K . Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol 1997; 124: 825–835.
Prause JU . Clinical ophthalmological tests for the diagnosis of keratoconjunctivitis sicca. Clin Exp Rheumatol 1989; 7: 141–144.
Lemp MA . Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J 1995; 21: 221–232.
Schiffman RM, Christanson MD, Jacobsen G . Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000; 118: 615–621.
Bawazeer AM, Hodge WG . One-minute Schirmer test with anaesthesia. Cornea 2003; 22: 285–287.
Ravazzoni L, Ghini C, Macri A, Rolando M . Forecasting of hydrophilic contact lens tolerance by means of tear ferning test. Graefe's Arch Clin Exp Ophthalmol 1998; 236: 354–358.
Chodosh J, Dix R, Howell RC, Dtroop WG, Tseng SC . Staining characteristics and antiviral activity of sulphorodamine B and lissamine green B. Invest Ophthalmol Vis Sci 1994; 35: 1046–1058.
Rosenberg ME, Tervo TM, Immonen IJ, Muller IJ, Vesaluoma MH . Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci 2000; 41: 2915–2921.
Xu KE, Yagi Y, Toda I, Tsubota K . Tear function index. A new measure of dry eye. Arch Ophthalmol 1995; 113: 84–88.
Tseng SCG . Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985; 92: 728–733.
Zweig MH, Campbell R . Receiver-Operating Characteristic (ROC) Plot. A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561–577.
Vitali C, Moutsopoulos HM, Bombardieri S . The European Community Study Group on diagnostic criteria for Sjogren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann Rheum Dis 1994; 53: 637–647.
Haga HJ, Hulten B, Bolstad AI, Ulvestad E, Jonsson R . Reliability and sensitivity of diagnostic tests for primary Sjogren's syndrome. J Rheumatol 1999; 26: 604–608.
Nichols KK, Mitchell GL, Zadnik K . The repeatability of clinical measurements of dry eye. Cornea 2004; 23: 272–285.
Hay EM, Thomas E, Pal B . Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998; 57: 20–24.
Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K . Three different types of dry eye syndrome. Cornea 1994; 13: 202–209.
Vissing A, Kalk WW, Mansour K, Spijkervet FK, Bootsma H . Comparison of lachrymal and salivary gland involvement in Sjogren's syndrome. Arch Otolaryngol Head Neck Surg 2003; 129: 966–971.
Calonge M, Diebold Y, Saez V . Impression cytology of the ocular surface: a review. Exp Eye Res 2004; 78: 457–472.
Rivas L, Murube J, Shalaby O, Oroza MA, Sanz AI . Impression cytology contribution to differential diagnosis of Sjogren's syndrome in the ophthalmological clinic. Arch Soc Esp Oftalmol 2002; 77: 63–72.
Brun JG, Jacobsen H, Kloster R, Cuida M, Johannesen AC, Hoyeraal HM et al. Use of a sicca symptoms questionnaire for the identification of patients with Sjogren's syndrome in a heterogeneous hospital population with various rheumatic diseases. Clin Exp Rheumatol 1994; 12: 649–652.
Bowman SJ, Booth DA, Platts RG . Validation of the Sicca Symptoms Inventory for clinical studies of Sjogren's syndrome. J Rheumatol 2003; 30: 1259–1266.
Tsubota K, Kaido M, Yagi Y, Fujihara T, Shimmura S . Diseases associated with ocular surface abnormalities: the importance of reflex tearing. Br J Ophthalmol 1999; 83: 89–91.
Tsubota K, Xu KP, Fujihara T, Katagiri S, Takeuchi T . Decreased reflex tearing is associated with lymphocytic infiltration in lachrymal glands. J Rheumatol 1996; 23: 313–320.
Sangwan VS, Tseng SCG . New perspectives in ocular surface disorders. An integrated approach for diagnosis and management. Indian J Ophthalmol 2001; 49: 153–168.
Hodges RR, Dartt DA . Regulatory pathways in lachrymal gland epithelium. Int Rev Cytol 2003; 231: 129–196.
Sade de Paiva C, Plugfelder SC . Tear clearance implications for ocular surface health. Exp Eye Res 2004; 78: 395–397.
Xu KP, Yagi Y, Tsubota K . Decrease in corneal sensitivity and change in tear function in dry eye. Cornea 1996; 15: 235–239.
Adatia FA, Michaeli-Cohen A, Naor J, Caffery B, Bookman A, Slomovic A . Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjogren's syndrome. Can J Ophthalmol 2004; 39: 767–771.
Tuominen ISJ, Konttinen YT, Vesaluoma MH, Moilanen JAO, Helinto M, Tervo TMT . Corneal innervation and morphology in primary Sjogren's Syndrome. Invest Ophthalmol Vis Sci 2003; 44: 2545–2549.
Kovacs L, Torok T, Bari F . Impaired microvascular response to cholinergic stimuli in primary Sjogren's syndrome. Ann Rheum Dis 2000; 59: 48–53.
Kovacs L, Papos M, Takacs F . Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjogren's syndrome. Clin Exp Rheumatol 2003; 21: 697–703.
Jonsson R, Haga HJ, Gordon TP . Current concepts on diagnosis, autoantibodies and therapy in Sjogren's syndrome. Scand J Rheumatol 2000; 29: 341–348.
Bacman S, Berra A, Sterin-Borda L, Borda E . Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren's syndrome. Invest Ophthalmol Vis Sci 2001; 42: 321–327.
Bacman S, Sterin-borda L, Camusso JJ . Circulating antibodies against rat parotid gland M-3 muscarinic receptors in primary Sjogren's syndrome. Clin Exp Immunol 1996; 104: 454–459.
Rolando M . Sjogren's syndrome as seen by an ophthalmologist. Scand J Rheumatol 2001; 115(suppl): 27–33.
Solomon A, Dursun D, Liu Z . Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry eye disease. Invest Ophthalmol Vis Sci 2001; 42: 2283–2292.
Acknowledgements
We are indebted to Mrs Chiara Coslovi, for her technical assistance and kindness with all of us.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Versura, P., Frigato, M., Cellini, M. et al. Diagnostic performance of tear function tests in Sjogren's syndrome patients. Eye 21, 229–237 (2007). https://doi.org/10.1038/sj.eye.6702204
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6702204
Keywords
This article is cited by
-
Unstimulated whole saliva flow for diagnosis of primary Sjögren’s syndrome: time to revisit the threshold?
Arthritis Research & Therapy (2020)
-
Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination
Eye (2019)
-
Association of Ramadan daytime fasting with ocular surface inflammation and dry eye
International Ophthalmology (2019)
-
Recommendations from the Brazilian society of rheumatology for the diagnosis of Sjögren’s syndrome (Part I): glandular manifestations (systematic review)
Advances in Rheumatology (2019)
-
Current Approach to Dry Eye Disease
Clinical Reviews in Allergy & Immunology (2015)
